065660 — Anterogen Co Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeSmall CapSucker Stock

Annual balance sheet for Anterogen Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st	2025 December 31st
Period Length:	—	—	—	—	—
Source:	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	59,009	55,968	50,334	39,654	43,585
Net Total Accounts Receivable
Net Total Receivables	4,907	4,196	3,923	3,998	3,232
Total Inventory
Prepaid Expenses
Total Current Assets	65,365	62,449	56,380	45,075	48,252
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	22,429	23,088	22,633	22,295	21,852
Net Goodwill
Net Intangible Assets
Long Term Investments
Other Long Term Assets
Total Assets	136,701	124,133	149,432	116,078	88,259
Accounts Payable
Payable / Accrued
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	13,755	15,037	10,759	1,482	618
Total Long Term Debt
Total Debt
Deferred Income Tax
Total Other Liabilities
Total Funded Status
Total Liabilities	19,834	17,341	19,987	5,867	813
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
ESOP Debt Guarantee
Unrealized Gain / Loss
Total Equity	116,867	106,791	129,445	110,212	87,446
Total Liabilities & Shareholders' Equity	136,701	124,133	149,432	116,078	88,259
Total Common Shares Outstanding